Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before October 14, 2025 to Discuss Your Rights – UNCY
1. Investors are urged to claim participation in a class action lawsuit. 2. Allegations include misleading statements about FDA compliance and drug application readiness. 3. The class period spans from March 29, 2024, to June 27, 2025. 4. The deadline for lead plaintiff applications is October 14, 2025. 5. The Gross Law Firm seeks to protect investor rights against corporate deception.